Barnidipine, a Novel Calcium Antagonist for Once-Daily Treatment of Hypertension: A Multicenter, Double-Blind, Placebo-Controlled, Dose-Ranging Study

By Hart Wimpeter   Holwerda Nicolas  

Cardiovascular Drugs and Therapy, Vol. 11, Iss. 5, 1997-11 ,pp. : 637-643

Springer Publishing Company

Access to resources Recommend Favorite

A Double-Blind, Placebo-Controlled Study of the Tolerability and Efficacy of a New Kappa-Opioid Receptor Agonist (R-84760) in Patients with Pain after Dental Surgery

By Seymour R.A.  

Clinical Drug Investigation, Vol. 20, Iss. 6, 2000-12 ,pp. : 409-414

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study

By Chrysant Steven G.  

Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. : 473-482

Adis International

Access to resources Recommend Favorite

Clinical Efficacy and Tolerability Evaluation of Pentoxifylline in Rheumatoid Arthritis: A Double-Blind, Randomised, Placebo-Controlled Study

By Usha P.R.   Naidu M.U.R.   Datla R.  

Clinical Drug Investigation, Vol. 22, Iss. 5, 2002-05 ,pp. : 329-339

Adis International

Access to resources Recommend Favorite

Speed of Onset, Efficacy and Tolerability of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine: A Randomised, Double-Blind, Placebo-Controlled Study

By David Dodick  

CNS Drugs, Vol. 19, Iss. 2, 2005-01 ,pp. : 125-136

Adis International

Access to resources Recommend Favorite